整合素α7与肿瘤关系的研究进展

doi:10.3969/j.issn.1004-616x.2020.04.013

[1] DESGROSELLIER J S, CHERESH D A. Integrins in cancer:biological implications and therapeutic opportunities[J]. Nat Rev Cancer, 2010, 10(1):9-22.
[2] SEGUIN L, DESGROSELLIER J S, WEIS S M, et al. Integrins and cancer:regulators of cancer stemness, metastasis, and drug resistance[J]. Trends Cell Biol, 2015, 25(4):234-240.
[3] BARCZYK M, CARRACEDO S, GULLBERG D. Integrins[J]. Cell Tissue Res, 2010, 339(1):269-280.
[4] BASORA N, VACHON P H, HERRING-GILLAM F E, et al. Relation between integrin alpha7Bbeta1 expression in human intestinal cells and enterocytic differentiation[J]. Gastroenterology, 1997, 113(5):1510-1521.
[5] BURKIN D J, KAUFMAN S J. The alpha7beta1 integrin in muscle development and disease[J]. Cell Tissue Res, 1999, 296(1):183-190.
[6] KRAMER R H, VU M P, CHENG Y F, et al. Laminin-binding integrin alpha 7 beta 1:functional characterization and expression in normal and malignant melanocytes[J]. Cell Regul, 1991, 2(10):805-817.
[7] WANG W, WU W, DESAI T, et al. Localization of the alpha 7 integrin gene (ITGA7) on human chromosome 12q13:clustering of integrin and Hox genes implies parallel evolution of these gene families[J]. Genomics, 1995, 26(3):568-570.
[8] GANGULY K K, PAL S, MOULIK S, et al. Integrins and metastasis[J]. Cell Adhesion Migr, 2013, 7(3):251-261.
[9] VIGNIER N, MOGHADASZADEH B, GARY F, et al. Structure, genetic localization, and identification of the cardiac and skeletal muscle transcripts of the human integrin alpha7 gene (ITGA7)[J]. Biochem Biophys Res Commun, 1999, 260(2):357-364.
[10] LI X M, WANG J J, ZHANG C, et al. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7[J]. J Pathol, 2018, 246(2):166-179.
[11] YANG G P, ZHANG T H, YE J N, et al. Circ-ITGA7 sponges miR-3187-3p to upregulate ASXL1, suppressing colorectal cancer proliferation[J]. Cancer Manag Res, 2019, 11:6499-6509.
[12] GAWLIK K I, MAYER U, BLOMBERG K, et al. Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan[J]. FEBS Lett, 2006, 580(7):1759-1765.
[13] HAAS T L, SCIUTO M R, BRUNETTO L, et al. Integrin α7 is a functional marker and potential therapeutic target in glioblastoma[J]. Cell Stem Cell, 2017, 21(1):35-50.e9.
[14] NIXON A M L, DUQUE A, YELLE N, et al. A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations[J]. Sci Rep, 2019, 9(1):842.
[15] MING X Y, FU L, ZHANG L Y, et al. Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma[J]. Nat Commun, 2016, 7:13568.
[16] SU Y, GUAN X Q, LIU F Q, et al. The effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells[J]. Int J Mol Med, 2014, 34(3):842-848.
[17] ULISSE S, BALDINI E, SORRENTI S, et al. The urokinase plasminogen activator system:a target for anti-cancer therapy[J]. Curr Cancer Drug Targets, 2009, 9(1):32-71.
[18] ZHANG Y R, TAO X M, JIN G Z, et al. A targetable molecular chaperone Hsp27 confers aggressiveness in hepatocellular carcinoma[J]. Theranostics, 2016, 6(4):558-570.
[19] CHIBA T, YOKOSUKA O, FUKAI K, et al. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells[J]. Oncology, 2004, 66(6):481-491.
[20] LIU J, ZHANG Z, LI X W, et al. Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression[J]. Oncogene, 2018, 37(41):5477-5491.
[21] BHANDARI A, XIA E J, ZHOU Y Y, et al. ITGA7 functions as a tumor suppressor and regulates migration and invasion in breast cancer[J]. Cancer Manag Res, 2018, 10:969-976.
[22] HUNG C M, KUO D H, CHOU C H, et al. Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells[J]. J Agric Food Chem, 2011, 59(17):9683-9690.
[23] YUAN Z Y, DAI T, WANG S S, et al. Overexpression of ETV4 protein in triple-negative breast cancer is associated with a higher risk of distant metastasis[J]. Onco Targets Ther, 2014, 7:1733-1742.
[24] DRIVALOS A, CHRISOFOS M, EFSTATHIOU E, et al. Expression of α 5-integrin, α7-integrin, E-cadherin, and N-cadherin in localized prostate cancer[J]. Urol Oncol, 2016, 34(4):165.e11-165.e18.
[25] TAN L Z, SONG Y, NELSON J, et al. Integrin α7 binds tissue inhibitor of metalloproteinase 3 to suppress growth of prostate cancer cells[J]. Am J Pathol, 2013, 183(3):831-840.
[26] ZHU Z H, YU Y P, ZHENG Z L, et al. Integrin alpha 7 interacts with high temperature requirement A2(HtrA2) to induce prostate cancer cell death[J]. Am J Pathol, 2010, 177(3):1176-1186.
[27] HAN Y C, YU Y P, NELSON J, et al. Interaction of integrin-linked kinase and miniature chromosome maintenance 7-mediating integrin {alpha}7 induced cell growth suppression[J]. Cancer Res, 2010, 70(11):4375-4384.
[28] LASZLO V, HODA M A, GARAY T, et al. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma[J]. J Pathol, 2015, 237(2):203-214.
[29] BURKIN D J, FONTELONGA T M. Mesothelioma cells breaking bad:loss of integrin α7 promotes cell motility and poor clinical outcomes in patients[J]. J Pathol, 2015, 237(3):282-284.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	WANG Miao, WANG Quankai, LI Xinwei, MA Shunpeng, WUHAN Baolier, XU Jianning. m⁶A methylation of mRNAs in glycidyl methacrylate-induced malignant transformation of 16HBE cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 405-409.
[2]	GAO Xiaobin, WU Xueliang, WANG Shengjie, SUN Guangyuan, WANG Wenjing, LIANG Feng, ZHAO Yifeng, LIU Zhenxian, ZHANG Yingchun. Expression of TRIM59 and its correlations with clinicopathological features in colorectal cancers [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 446-450.
[3]	. [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 470-474.
[4]	. [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 475-481.
[5]	CUI Zhaoyang, LI Suna, JIANG Xuqian, WANG Yidan, HOU Liying. Activation of the TRAIL death receptor by apigenin for induction of apoptosis in the gastric cancer SGC-7901 cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(1): 32-36.
[6]	. [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(1): 72-76.
[7]	LI Jinglei, HOU Wei. ceRNA network-based stigmasterolintervention on lung squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 423-429.
[8]	SHI Hailin, HE Tianji, LIU Feng, CAI Menghui, GE Bo. Prognostic value of TCGA-database mutation burden in muscle-invasive bladder cancers [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 430-437,443.
[9]	. [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 477-480,484.
[10]	. [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 485-489.
[11]	LUAN Yiran, LIU Liyuan, JIAO Long, WANG Yueling, BAI Hanyu, ZOU Naiyi, MA Ming. Clinical significance of miR-429 and Bmi-1 mRNA expression in diffuse large B-cell lymphoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(3): 177-181.
[12]	GULZARIA·Aikula, TAN Yao, PALIDA·Apiziaji. Expression of long non-coding RNAs in esophageal squamous cell carcinoma of Kazak nationality in Xinjiang [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(3): 194-197,202.
[13]	SHU Zhixiong, WU Chuancheng, WU Xiaoli, LIU Baoying. Relationships between gastric cancer and SNPs of autophagy-related genes on the PI3K/Akt/mTOR pathway [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(2): 118-125,131.
[14]	. [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(1): 67-71.
[15]	MA Xiaobiao, ZHANG Qi, PAN Dingguo. Association between rs4143815 polymorphism in the B7-H1 gene and risk of colorectal cancer [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(6): 440-443,448.